Your browser doesn't support javascript.
loading
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Adriaenssens, Niels; Scholtes, Beatrice; Bruyndonckx, Robin; Van Ngoc, Pauline; Verbakel, Jan Yvan Jos; De Sutter, An; Heytens, Stefan; Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; Goossens, Herman; Buret, Laetitia; Duysburgh, Els; Coenen, Samuel.
Afiliação
  • Adriaenssens N; Family Medicine & Population Health, Centre for General Practice, University of Antwerp Faculty of Medicine and Health Sciences, Antwerp (Wilrijk), Belgium.
  • Scholtes B; General Practice Department, Primary Care and Health Research Unit, Liege University, Liege, Belgium.
  • Bruyndonckx R; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Hasselt University, Hasselt, Limburg, Belgium.
  • Van Ngoc P; Epidemiology & Pharmacovigilance, P95, Leuven, Belgium.
  • Verbakel JYJ; Vaccine & Infectious Disease Institute, Laboratory of Medical Microbiology, University of Antwerp, Antwerp (Wilrijk), Belgium.
  • De Sutter A; General Practice Department, Primary Care and Health Research Unit, Liege University, Liege, Belgium.
  • Heytens S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Van Den Bruel A; Department of Public Health and Primary Care, KU Leuven, Leuven, Flanders, Belgium.
  • Desombere I; Department of Public Health and Primary Care, Ghent University, Gent, Belgium.
  • Van Damme P; Department of Public Health and Primary Care, Ghent University, Gent, Belgium.
  • Goossens H; Department of Public Health and Primary Care, KU Leuven, Leuven, Flanders, Belgium.
  • Buret L; Department of Infectious Diseases in Humans, Sciensano, Brussels, Belgium.
  • Duysburgh E; Vaccine & Infectious Disease Institute, Centre for the Evaluation of Vaccination, University of Antwerp Faculty of Medicine and Health Sciences, Antwerp (Wilrijk), Belgium.
  • Coenen S; Vaccine & Infectious Disease Institute, Laboratory of Medical Microbiology, University of Antwerp, Antwerp (Wilrijk), Belgium.
BMJ Open ; 12(9): e065897, 2022 09 19.
Article em En | MEDLINE | ID: mdl-36123069

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article